Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease-Reference-Cited by-同舟云学术

Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease

Published:2020-06-19 Issue:25 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Shi Hongpeng¹^ORCID,Xue Tong²^ORCID,Yang Yang³,Jiang Chenyu¹^ORCID,Huang Shixing¹^ORCID,Yang Qi¹,Lei Dong⁴,You Zhengwei⁴,Jin Tuo²,Wu Fei²^ORCID,Zhao Qiang¹^ORCID,Ye Xiaofeng¹^ORCID

Affiliation:

1. Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P. R. China.

2. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, P. R. China.

3. Department of Cardiothoracic Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, P. R. China.

4. State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, International Joint Laboratory for Advanced Fiber and Low-Dimension Materials, College of Materials Science and Engineering Donghua University, Shanghai 201620, P. R. China.

Abstract

Phase transition microneedles provide an optimal administration method for cardiac gene therapy.

Funder

Natural Science Foundation of Shanghai

National Natural Science Foundation of China

Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support

Shanghai Municipal Key Clinical Specialty Construction Project

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference58 articles.